blog ; MabDesign ; articles ; expertise ; pipeline ; données marché

Welcome to the MabDesign blog

As an association representing the biomedical industry, part of our mission is to put our expertise at the service of innovation and the companies behind it. If you haven’t heard of MabDesign yet, we invite you to take a look at our about us page to find out more !

On this blog, you’ll find a wealth of information on the biopharmaceutical industry: themed pipeline analyses, explanatory articles on biopharmaceuticals, biomanufacturing and all that goes with it, and our famous immunowatches and bioprocess watches.

Advanced therapy medicinal products: from the lab to the patient's bed
Advanced therapy medicinal products: from the lab to the patient's bed
Advanced therapy medicinal products (ATMPs) explore new therapeutic approaches based on genome modification, manipulation of patient or healthy donor cells and other innovative methods, representing a major transition from traditional medicine to more personalized and targeted medicine.
The history of biologics: from discovery to therapeutic revolution
The history of biologics: from discovery to therapeutic revolution
Biopharmaceuticals, or biotherapies, are becoming increasingly important on the market, and offer immense hope for the treatment of many diseases. From the first discoveries of vaccines to the recent development of cell and gene therapies and regenerative medicine, looking back at biologics' history lets us have a better understanding of the revolution that they provoked in the pharmaceutical industry and…
Vaccins thérapeutiques en oncologie
Vaccins thérapeutiques en oncologie
L'analyse marché MabDesign de ce mois-ci vous donne un aperçu du marché des vaccins thérapeutiques en oncologie.
Anticorps conjugués
Anticorps conjugués
L'analyse marché MabDesign de ce mois-ci vous donne un aperçu du marché et des projets d'anticorps conjugués (antibody-drug conjugates) en développement.
Prophylactic or Therapeutic : what does the future hold for vaccines ?
Prophylactic or Therapeutic : what does the future hold for vaccines ?
Fuelled by decades of innovation, vaccines are an essential tool in the fight against disease. Historically focused on prophylaxis to prevent the spread of infectious diseases, new generations of vaccines are now being developed and/or are already available in other therapeutic areas including oncology. Historically focused on prophylaxis and infectious diseases, they are now opening up to new avenues of…
Monoclonal antibodies: the stars of therapeutic proteins
Monoclonal antibodies: the stars of therapeutic proteins
Hybridoma technology for the production of monoclonal antibodies (mAbs), awarded the Nobel Prize for Medicine in 1984, revolutionized serotherapy, which previously used patient serum containing mixtures of antibodies. More targeted and therefore more effective, mAbs offer innovative perspectives in the treatment of various diseases, and have become an essential therapeutic strategy in our pharmaceutical arsenal.
Troubles neurologiques
Troubles neurologiques
L'analyse de marché MabDesign de ce mois-ci vous donne un aperçu de la dynamique marché et des projets en développement ciblant des troubles neurologiques.